Azosemide
Drug profile
Also known as: azosemid, diurapid
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Azosemide is a drug catalogued in DrugCentral. Recorded indications include Congestive heart failure.
- Indications: Congestive heart failure.
- Molecular formula: C12H11ClN6O2S2; molecular weight 370.83 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Congestive heart failure
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Cardiac failure | 802.3 |
| Renal impairment | 512.6 |
| Cardiac failure chronic | 357.2 |
| Blood pressure decreased | 202.3 |
| Cerebral infarction | 194.9 |
| Hepatic function abnormal | 192.5 |
| Dehydration | 150.0 |
| Brain natriuretic peptide increased | 147.3 |
| Concomitant disease aggravated | 140.8 |
| Pulmonary arterial hypertension | 134.3 |
| Cardiac failure acute | 130.8 |
| Hyperkalaemia | 115.7 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Azosemide is on its molecule page.
| Molecular formula | C12H11ClN6O2S2 |
|---|---|
| Molecular weight | 370.83 g/mol |
| CAS number | 27589-33-9 |
| InChIKey | HMEDEBAJARCKCT-UHFFFAOYSA-N |
| PubChem CID | 2273 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Azosemide used for?
DrugCentral lists the following indications for Azosemide: Congestive heart failure.
What is the chemical formula of Azosemide?
Azosemide has the molecular formula C12H11ClN6O2S2 and a molecular weight of 370.83 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 278 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1097235 — compound record and bioactivity
- PubChem CID 2273 — chemical identifiers
- DrugBank DB08961 — drug record
- FDA UNII MR40VT1L8Z — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.